BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 18497982)

  • 21. The antibacterial drug taurolidine induces apoptosis by a mitochondrial cytochrome c-dependent mechanism.
    Han Z; Ribbizi I; Pantazis P; Wyche J; Darnowski J; Calabresi P
    Anticancer Res; 2002; 22(4):1959-64. PubMed ID: 12174870
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The multikinase inhibitor sorafenib potentiates TRAIL lethality in human leukemia cells in association with Mcl-1 and cFLIPL down-regulation.
    Rosato RR; Almenara JA; Coe S; Grant S
    Cancer Res; 2007 Oct; 67(19):9490-500. PubMed ID: 17909059
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gossypol, a phytochemical with BH3-mimetic property, sensitizes cultured thoracic cancer cells to Apo2 ligand/tumor necrosis factor-related apoptosis-inducing ligand.
    Yeow WS; Baras A; Chua A; Nguyen DM; Sehgal SS; Schrump DS; Nguyen DM
    J Thorac Cardiovasc Surg; 2006 Dec; 132(6):1356-62. PubMed ID: 17140955
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [In vitro effect of taurolidine on squamous cell carcinoma in the oral cavity].
    Petrovic L; Schlegel KA; Ries J; Park J; Diebel E; Schultze-Mosgau S; Wiltfang J
    Mund Kiefer Gesichtschir; 2003 Mar; 7(2):102-7. PubMed ID: 12664255
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effects of recombinant human tumor-necrosis factor related to apoptosis inducing ligand protein on apoptosis of human lung adenocarcinoma cell line resistant to cisplatin].
    Zhang M; Hu C; Chen Q; Yang H
    Zhongguo Fei Ai Za Zhi; 2005 Oct; 8(5):419-23. PubMed ID: 21205524
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Synergistic effects and mechanisms of combined tumor necrosis factor-related apoptosis-inducing ligand and chemotherapeutic drugs or radiotherapy in killing laryngeal squamous carcinoma cells in vitro].
    Zhang M; Zhou L
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2009 Jul; 44(7):565-70. PubMed ID: 19957654
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Valproic acid sensitizes TRAIL-resistant anaplastic thyroid carcinoma cells to apoptotic cell death.
    Cha HY; Lee BS; Kang S; Shin YS; Chang JW; Sung ES; Kim YS; Choi JW; Kim JH; Kim CH
    Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S716-24. PubMed ID: 23982257
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tumor Cell-selective Synergism of TRAIL- and ATRA-induced Cytotoxicity in Breast Cancer Cells.
    Reinhardt A; Liu H; Ma Y; Zhou Y; Zang C; Habbel JP; Possinger K; Eucker J
    Anticancer Res; 2018 May; 38(5):2669-2682. PubMed ID: 29715087
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Imatinib enhances human melanoma cell susceptibility to TRAIL-induced cell death: Relationship to Bcl-2 family and caspase activation.
    Hamaï A; Richon C; Meslin F; Faure F; Kauffmann A; Lecluse Y; Jalil A; Larue L; Avril MF; Chouaib S; Mehrpour M
    Oncogene; 2006 Dec; 25(58):7618-34. PubMed ID: 16983347
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Synergistic apoptotic effect of the combination of diosgenin and TRAIL on non-small-cell lung cancer cell line A549 evaluated with the Chou-Talalay method].
    He Y; Wang JS; Zhang P; Zhang WJ; Huang QL; Hua ZC
    Yao Xue Xue Bao; 2013 Jan; 48(1):45-51. PubMed ID: 23600140
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The proteasome inhibitor MG132 potentiates TRAIL receptor agonist-induced apoptosis by stabilizing tBid and Bik in human head and neck squamous cell carcinoma cells.
    Sung ES; Park KJ; Choi HJ; Kim CH; Kim YS
    Exp Cell Res; 2012 Aug; 318(13):1564-76. PubMed ID: 22513214
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effects of taurolidine, a novel antineoplastic agent, on human malignant mesothelioma.
    Nici L; Monfils B; Calabresi P
    Clin Cancer Res; 2004 Nov; 10(22):7655-61. PubMed ID: 15569998
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combination of Ad-sTRAIL with the chemotherapeutic drug cisplatin synergistically enhances their pro-apoptotic ability in human breast cancer cells.
    Liu X; Wang J; Wang H; Liu S; Liang Y; Lv Z; Zhou Q; Ding W
    Oncol Rep; 2013 Oct; 30(4):1913-9. PubMed ID: 23912708
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of antiapoptotic proteins in tumor necrosis factor-related apoptosis-inducing ligand and cisplatin-augmented apoptosis.
    Kim JH; Ajaz M; Lokshin A; Lee YJ
    Clin Cancer Res; 2003 Aug; 9(8):3134-41. PubMed ID: 12912965
    [TBL] [Abstract][Full Text] [Related]  

  • 35. TNF-related apoptosis-inducing ligand enhances vinorelbine-induced apoptosis and antitumor activity in a preclinical model of non-small cell lung cancer.
    Zhu K; Fang W; Chen Y; Lin S; Chen X
    Oncol Rep; 2014 Sep; 32(3):1234-42. PubMed ID: 25017445
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enhanced caspase-8 recruitment to and activation at the DISC is critical for sensitisation of human hepatocellular carcinoma cells to TRAIL-induced apoptosis by chemotherapeutic drugs.
    Ganten TM; Haas TL; Sykora J; Stahl H; Sprick MR; Fas SC; Krueger A; Weigand MA; Grosse-Wilde A; Stremmel W; Krammer PH; Walczak H
    Cell Death Differ; 2004 Jul; 11 Suppl 1():S86-96. PubMed ID: 15105837
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Downmodulation of dimethyl transferase activity enhances tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in prostate cancer cells.
    Festuccia C; Gravina GL; D'Alessandro AM; Millimaggi D; Di Rocco C; Dolo V; Ricevuto E; Vicentini C; Bologna M
    Int J Oncol; 2008 Aug; 33(2):381-8. PubMed ID: 18636160
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Irigenin sensitizes TRAIL-induced apoptosis via enhancing pro-apoptotic molecules in gastric cancer cells.
    Xu Y; Gao CC; Pan ZG; Zhou CW
    Biochem Biophys Res Commun; 2018 Feb; 496(3):998-1005. PubMed ID: 29305260
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enhancement of Fas-ligand-mediated programmed cell death by taurolidine.
    Stendel R; Scheurer L; Stoltenburg-Didinger G; Brock M; Möhler H
    Anticancer Res; 2003; 23(3B):2309-14. PubMed ID: 12894508
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cooperative cytotoxicity of proteasome inhibitors and tumor necrosis factor-related apoptosis-inducing ligand in chemoresistant Bcl-2-overexpressing cells.
    Nencioni A; Wille L; Dal Bello G; Boy D; Cirmena G; Wesselborg S; Belka C; Brossart P; Patrone F; Ballestrero A
    Clin Cancer Res; 2005 Jun; 11(11):4259-65. PubMed ID: 15930365
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.